Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb 1;106(2):e158-e160.
doi: 10.1097/TP.0000000000003999.

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

Nicola Cotugno  1   2 , Chiara Pighi  1 , Elena Morrocchi  1 , Alessandra Ruggiero  1 , Donato Amodio  1 , Chiara Medri  1 , Luna Colagrossi  3 , Cristina Russo  3 , Silvia Di Cesare  1 , Veronica Santilli  1 , Emma Concetta Manno  1 , Paola Zangari  1 , Carmela Giancotta  1 , Stefania Bernardi  1 , Luciana Nicolosi  1 , Marta Ciofi Degli Atti  4 , Massimiliano Raponi  4 , Salvatore Zaffina  5 , Sara Alfieri  6 , Richard Kirk  6 , Carlo Federico Perno  3 , Paolo Rossi  1   2 , Antonio Amodeo  6 , Paolo Palma  1   2
Affiliations
Comment

BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?

Nicola Cotugno et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Comment on

References

    1. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206.
    1. Cotugno N, Ruggiero A, Bonfante F, et al.; CACTUS Study Team. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies. Cell Rep. 2021;34:108852.
    1. Del Bello A, Abravanel F, Marion O, et al. Efficiency of a boost with a third dose of anti–SARS-CoV-2 messenger RNA–based vaccines in solid organ transplant recipients. Am J Transplant. 2022;22:322–323.
    1. Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662.
    1. Tregoning JS, Flight KE, Higham SL, et al. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21:626–636.